Key Insights

Highlights

Success Rate

82% trial completion

Published Results

25 trials with published results (20%)

Research Maturity

77 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.6%

17 terminated out of 125 trials

Success Rate

81.9%

-4.6% vs benchmark

Late-Stage Pipeline

10%

12 trials in Phase 3/4

Results Transparency

32%

25 of 77 completed with results

Key Signals

25 with results82% success17 terminated

Data Visualizations

Phase Distribution

71Total
Not Applicable (42)
Early P 1 (5)
P 1 (6)
P 2 (6)
P 3 (2)
P 4 (10)

Trial Status

Completed77
Terminated17
Unknown14
Recruiting10
Withdrawn2
Enrolling By Invitation2

Trial Success Rate

81.9%

Benchmark: 86.5%

Based on 77 completed trials

Clinical Trials (125)

Showing 20 of 20 trials
NCT07335445Not ApplicableNot Yet RecruitingPrimary

Enhancing Screening Practices for BE

NCT00587314Enrolling By InvitationPrimary

The Effect of Ablation Therapy on Barrett's Esophagus

NCT04880044Not ApplicableCompletedPrimary

Detection of Barrett s Esophagus in Patients Without GERD Symptoms

NCT06523374Not ApplicableRecruitingPrimary

A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

NCT02947971Not ApplicableRecruitingPrimary

Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System

NCT02422433Not ApplicableActive Not RecruitingPrimary

Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule

NCT04408105Completed

Survey Study on Barrett's Esophagus Screening

NCT02534233Not ApplicableCompletedPrimary

Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium

NCT00288119RecruitingPrimary

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

NCT05965921Completed

Real-life Prospective Evaluation of Computer-aided Detection (CAD) of Barrett's Neoplasia

NCT02427269Enrolling By InvitationPrimary

University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository

NCT06748911Not ApplicableRecruitingPrimary

Navicam for Detection of Barrett's Esophagus

NCT02198976RecruitingPrimary

Australian Barrett's Cohort With Dysplasia and Early Cancer Study

NCT02634645RecruitingPrimary

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

NCT00590239RecruitingPrimary

Barrett's Esophagus Related Neoplasia (BERN) Project

NCT05740189Not ApplicableRecruitingPrimary

CBAS180 De-escalation Study

NCT05645679UnknownPrimary

Efficacy and Safety of HYbrid Argon Plasma Coagulation Technique in Patients With Barrett's Esophagus-Related Dysplasia

NCT03813381Not ApplicableCompletedPrimary

CAlorie and Protein REstriction PROgram in Barrett's Esophagus Patients (CARE-PRO).

NCT02579460Not ApplicableCompletedPrimary

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition

NCT02200250WithdrawnPrimary

Long Term Barrett's Endoscopic Mucosal Resection Study

Scroll to load more

Research Network

Activity Timeline